Literature DB >> 25510696

Endometriosis and the subsequent risk of epithelial ovarian cancer.

Wen-Hsun Chang1, Kuan-Chin Wang2, Wen-Ling Lee3, Nicole Huang4, Yiing-Jeng Chou4, Rung-Chuang Feng5, Ming-Shyen Yen6, Ben-Shian Huang7, Chao-Yu Guo8, Peng-Hui Wang9.   

Abstract

OBJECTIVE: There is a possible correlation between endometriosis and an increased risk of epithelial ovarian cancer (EOC), but many uncertainties remain, including race, exposure or surveillance time, and surgical confirmation. Therefore, we carried out a large-scale, nationwide, controlled cohort study in the Taiwanese women to respond to these uncertainties.
MATERIALS AND METHODS: A historical cohort study was performed by linking the National Health Insurance Research Database of Taiwan. Each patient diagnosed with endometriosis (n = 7537) between 2000 and 2009 was background matched with up to two women without endometriosis (n = 15,074). The total was 136,643 person-years of follow-up and 24 women having new EOC. Cox regression analysis was used to determine the relationship between the EOC incidence rate and an endometriosis status.
RESULTS: The EOC incidence rate of the endometriosis and non-endometriosis women was 3.31 per 10,000 person-years and 0.99 per 10,000 person-years, respectively, contributing to an adjusted hazard ratio (HR) of 3.28 (95% confidence interval, 1.37-7.85). The women with surgical confirmation had a much higher adjusted HR (3.87; 95% confidence interval, 1.58-9.47). No significantly statistical difference of surveillance time between women with and without endometriosis (3.87 years vs. 3.73 years). The occurrence of EOC was not also affected by exposure time of women with endometriosis.
CONCLUSION: Taiwanese women with endometriosis really had a risk of newly developed EOC, especially those who had a surgical diagnosis, and this three-fold increase of risk was neither influenced by exposure time nor biased by surveillance.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Cohort study; Endometriosis; Epithelial ovarian cancer; Risk; Surgical diagnosis

Mesh:

Year:  2014        PMID: 25510696     DOI: 10.1016/j.tjog.2014.04.025

Source DB:  PubMed          Journal:  Taiwan J Obstet Gynecol        ISSN: 1028-4559            Impact factor:   1.705


  10 in total

1.  Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.

Authors:  Tze-Kiong Er; Yu-Fa Su; Chun-Chieh Wu; Chih-Chieh Chen; Jing Wang; Tsung-Hua Hsieh; Marta Herreros-Villanueva; Wan-Tzu Chen; Yi-Ting Chen; Ta-Chih Liu; Hung-Sheng Chen; Eing-Mei Tsai
Journal:  J Mol Med (Berl)       Date:  2016-02-27       Impact factor: 4.599

2.  Long-term Health Consequences of Endometriosis - Pathways and Mediation by Treatment.

Authors:  Leslie V Farland; Holly R Harris
Journal:  Curr Obstet Gynecol Rep       Date:  2020-05-29

3.  Endometriosis Might Be Inversely Associated with Developing Chronic Kidney Disease: A Population-Based Cohort Study in Taiwan.

Authors:  Ben-Shian Huang; Wen-Hsun Chang; Kuan-Chin Wang; Nicole Huang; Chao-Yu Guo; Yiing-Jen Chou; Hsin-Yi Huang; Tzeng-Ji Chen; Wen-Ling Lee; Peng-Hui Wang
Journal:  Int J Mol Sci       Date:  2016-07-07       Impact factor: 5.923

4.  Risks of female genital tract related cancers (gynecological cancers) or breast cancer in women with and without chronic kidney disease: A population-based cohort study in Taiwan.

Authors:  Wen-Hsun Chang; Huann-Cheng Horng; Chang-Ching Yeh; Chao-Yu Guo; Yiing-Jeng Chou; Nicole Huang; Hsin-Yi Huang; Yi-Jen Chen; Wen-Ling Lee; Peng-Hui Wang
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

5.  Subsequent Development of Epithelial Ovarian Cancer After Ovarian Surgery for Benign Ovarian Tumor: A Population-Based Cohort Study.

Authors:  Chen-Yu Huang; Wen-Hsun Chang; Hsin-Yi Huang; Chao-Yu Guo; Yiing-Jenq Chou; Nicole Huang; Wen-Ling Lee; Peng-Hui Wang
Journal:  Clin Epidemiol       Date:  2020-06-18       Impact factor: 4.790

6.  Asian Society of Gynecologic Oncology International Workshop 2018.

Authors:  Tae Wook Kong; Hee Sug Ryu; Seung Cheol Kim; Takayuki Enomoto; Jin Li; Kenneth H Kim; Seung Hyuk Shim; Peng Hui Wang; Suwanit Therasakvichya; Yusuke Kobayashi; Maria Lee; Tingyan Shi; Shin Wha Lee; Mikio Mikami; Satoru Nagase; Myong Cheol Lim; Jianliu Wang; Sarikapan Wilailak; Sang Wun Kim; Sook Hee Hong; David Sp Tan; Masaki Mandai; Suk Joon Chang; Ruby Yun Ju Huang; Kimio Ushijima; Jung Yun Lee; Xiaojun Chen; Kazunori Ochiai; Taek Sang Lee; Bingyi Yang; Farhana Kalam; Qiaoying Lv; Mohd Faizal Ahmad; Muhammad Rizki Yaznil; Kanika Batra Modi; Manatsawee Manopunya; Dae Hoon Jeong; Arb Aroon Lertkhachonsuk; Hyun Hoon Chung; Hidemichi Watari; Seob Jeon
Journal:  J Gynecol Oncol       Date:  2019-01-14       Impact factor: 4.401

7.  Contralateral ovarian endometrioma recurrence after unilateral salpingo-oophorectomy.

Authors:  Tokie Hidari; Tetsuya Hirata; Tomoko Arakawa; Kaori Koga; Kazuaki Neriishi; Shinya Fukuda; Akari Nakazawa; Natsuki Nagashima; Suke Ma; Hui Sun; Masashi Takamura; Miyuki Harada; Yasushi Hirota; Osamu Wada-Hiraike; Tomoyuki Fujii; Yutaka Osuga
Journal:  BMC Womens Health       Date:  2019-05-02       Impact factor: 2.809

8.  The Risk of Epithelial Ovarian Cancer of Women With Endometriosis May be Varied Greatly if Diagnostic Criteria Are Different: A Nationwide Population-Based Cohort Study.

Authors:  Wen-Ling Lee; Wen-Hsun Chang; Kuan-Chin Wang; Chao-Yu Guo; Yiing-Jeng Chou; Nicole Huang; Hsin-Yi Huang; Ming-Shyen Yen; Peng-Hui Wang
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

Review 9.  Clinical implication for endometriosis associated with ovarian cancer.

Authors:  Pao-Ling Torng
Journal:  Gynecol Minim Invasive Ther       Date:  2017-08-30

10.  Risk of Endometriosis and Subsequent Ovary and Breast Cancers in Nurses: A Population-Based Cohort Study in Taiwan.

Authors:  Hsing-Chi Hsu; Kai-Yu Tseng; Hsiang-Chi Wang; Fung-Chan Sung; Wei-Fen Ma
Journal:  Int J Environ Res Public Health       Date:  2019-09-18       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.